CMK SELECT
43 Route 46 East, Suite 705 Pine Brook, NJ 07058 USA
Rachel Phone: (973) 244-6060

FORGOT YOUR DETAILS?

+ Filters

Select one or more of the filter options below

CLOSE

Thought Leadership

Building on a Solid Foundation to Achieve Launch Excellence

AUTHOR: B.Turakhia

Create the plan. Execute the plan. Sounds easy, doesn’t it? Yet, if you’ve launched a product in healthcare, you know the reality. Even with a…

CONTINUE READING

Five Common Barriers to Optimal Launch Trajectory (Part 2 of 2)

AUTHOR: B.Turakhia

Fifty percent of new drug launches do not achieve peak sales, with half of them missing their targeted goals by 50% or more.1 How can…

CONTINUE READING

Case for an IT-enabling Business Strategy for companies in the Life Sciences Industry

AUTHOR: D. Douglas

The major trends in the life sciences industry are profoundly affecting the way we all work – from conducting research to distributing products, and everything…

CONTINUE READING

The Continuously Increasing Value of Medical Affairs in Product Launches – Part I

AUTHOR: N. Borinshteyn

Bringing each new pharmaceutical product to market is a complex and somewhat unique process led and executed by a cross-functional team who undertakes a number…

CONTINUE READING

Do Brands Have Value After Exclusivity?

AUTHOR: I. Deza

When a successful product is about to lose its exclusivity, and is facing incursions by generics or biosimilars, a pharmaceutical manufacturer sometimes decides to walk…

CONTINUE READING

Five Common Barriers to Optimal Launch Trajectory (Part 1)

AUTHOR: B.Turakhia

New Drug Launch, Day 1… The most anticipated and pivotal day for a pharmaceutical company. It takes an average of 14 years and $2.6 billion…

CONTINUE READING

The Rising Value of Medical Affairs

AUTHOR: N. Borinshteyn

It’s not news that market pressures are driving the healthcare industry’s increasing medical orientation. Recognized trends that are leading this shift include: Growing prevalence of…

CONTINUE READING

Five Best Practices for Maintaining Sunshine Act Compliance

AUTHOR: CMK SELECT

How drug companies can avoid penalties, revenue loss, resource drain, reputation issues, and relationship challenges With the passing of the Physician Payments Sunshine Act, the…

CONTINUE READING

Implementing the Plan for Launch Excellence

AUTHOR: B.Turakhia

You’re approved! The months of preparation are in the past. It’s time to launch. By now, you’ve accomplished so much: You’ve built a rock-solid strategic…

CONTINUE READING

Ensuring Launch Success with KPIs

AUTHOR: D. Yerranguntla

KPIs, or key performance indicators, are critical to the success of a pharmaceutical product launch. By their very definition, KPIs are measurable values that demonstrate…

CONTINUE READING

LIKE OUR PAGE

FOLLOW US

GET LINKED IN

TOP